Eton Pharmaceuticals, Inc. (ETON) Social Stream
ETON PHARMACEUTICALS INC (ETON) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ETON PHARMACEUTICALS INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ETON's average price target has moved down $4.33 over the prior 39 months.
ETON reports an average of 180.74% for its upside potential over the past 31 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ETON Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
ETON's average broker recommendation rating improved by 0 over the prior 153 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ETON as an investment opportunity.
- In the context of all US stocks, ETON PHARMACEUTICALS INC's number of analysts covering the stock is higher than 8.64% of them.
- ETON PHARMACEUTICALS INC's variance in analysts' estimates is lower than 66.75% of Pharmaceutical Products stocks.
- In terms of how ETON PHARMACEUTICALS INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 89.32% of that group.
- In the context of Healthcare stocks, ETON PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 303% of them.
Make investment decisions regarding ETON using the data that counts. Try POWR Ratings for free.